COMERICA BANK - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 276 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMERICA BANK ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$535,720
-21.7%
13,393
-14.1%
0.00%
-33.3%
Q1 2024$684,601
-34.0%
15,591
-7.0%
0.00%
-40.0%
Q4 2023$1,037,224
+39.6%
16,770
+3.8%
0.01%
+25.0%
Q3 2023$742,739
+123483.9%
16,150
-22.2%
0.00%
-20.0%
Q4 2022$601
-99.9%
20,752
-24.8%
0.01%
-28.6%
Q3 2022$852,000
-23.2%
27,592
-8.9%
0.01%
-22.2%
Q2 2022$1,109,000
-6.0%
30,272
+0.3%
0.01%0.0%
Q1 2022$1,180,000
+37.2%
30,182
-12.6%
0.01%
+50.0%
Q4 2021$860,000
+40.3%
34,517
+8.1%
0.01%
+50.0%
Q3 2021$613,000
+0.5%
31,927
-2.2%
0.00%0.0%
Q2 2021$610,000
-0.7%
32,650
-7.8%
0.00%0.0%
Q1 2021$614,000
-10.9%
35,429
-3.9%
0.00%0.0%
Q4 2020$689,000
-10.3%
36,857
-0.0%
0.00%
-33.3%
Q3 2020$768,000
+7.9%
36,868
+6.8%
0.01%
+20.0%
Q2 2020$712,000
+27.6%
34,533
+3.6%
0.01%0.0%
Q1 2020$558,000
-11.8%
33,334
+1.9%
0.01%0.0%
Q4 2019$633,000
-0.9%
32,728
-0.0%
0.01%0.0%
Q3 2019$639,000
-3.8%
32,742
-1.2%
0.01%0.0%
Q2 2019$664,000
-9.0%
33,155
-4.5%
0.01%
-16.7%
Q1 2019$730,000
-2.7%
34,703
+2.1%
0.01%0.0%
Q4 2018$750,000
+20.6%
33,981
-0.4%
0.01%
+20.0%
Q3 2018$622,000
-0.5%
34,120
-10.4%
0.01%
+25.0%
Q2 2018$625,000
-13.3%
38,063
+2.8%
0.00%
-20.0%
Q1 2018$721,000
+2.1%
37,028
+1.3%
0.01%0.0%
Q4 2017$706,000
+3.8%
36,536
-2.5%
0.01%0.0%
Q3 2017$680,000
+2.3%
37,490
-0.0%
0.01%0.0%
Q2 2017$665,000
+10.8%
37,492
-5.4%
0.01%0.0%
Q1 2017$600,000
-8.0%
39,612
+4.1%
0.01%0.0%
Q4 2016$652,000
-3.6%
38,042
+7.4%
0.01%
-16.7%
Q3 2016$676,00035,4140.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders